Latest From ResMed Inc.
German Industry Says MDR Implementation 'Too Slow' But Negative Economic Effects Still Largely Unreported
The European Commission needs to be faster and more efficient in its implementation of the new EU Medical Device Regulation (MDR), say German manufacturers, watching the remaining months of transition time slip into single figures. A few economic operators have come clean about the pressure the MDR has brought to bear, but the suspicion is that many are choosing to keep quiet.
ResMed expects to pay more than $40m to settle a Department of Justice investigation into the company’s resupply program.
A new multinational analysis by ResMed showed that the number of people with sleep apnea is 10 times higher than previous estimates by the World Health Organization, raising the need for developing strategies to raise awareness of the disease and diagnose and treat the disease.
- Diagnostic Equipment & Supplies
- Monitoring Equipment & Devices
- Therapeutic Areas
- Neurology, Nervous System
- Respiratory, Pulmonary
- North America
- Parent & Subsidiaries
- ResMed Inc.
- Senior Management
Michael Farrell, CEO
Robert Douglas, Pres. & COO
- Contact Info
Phone: (858) 836-5000
9001 Spectrum Ctr. Blvd.
San Diego, CA 92123
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.